Recrown Medical: Pioneering an Intelligent and Diversified Path for Laparoscopic Surgical Robotics

Laparoscopic surgery is a minimally invasive surgical procedure performed through small incisions, widely used in departments such as general surgery, urology, hepatobiliary surgery, gastroenterology, thyroid and breast surgery, and gynecology. In China, over 9 million laparoscopic surgeries are performed annually, with a potential annual volume reaching up to 20 million. From the era 1.0 of open surgery with large incisions, to the era 2.0 of minimally invasive video-assisted laparoscopic surgery, and now to the ongoing era 3.0 of robot-assisted surgery, surgical trauma has become increasingly minimal, operations more precise, blood loss reduced, and patient recovery accelerated.

However, the issues hindering the further development of endoscopic surgery include:

1. Unstable pneumoperitoneum, surgeon fatigue, and susceptibility of the endoscope to interference result in poor surgical stability and a high incidence of complications;

2. Intraoperative smoke poses a serious hazard to the health of medical staff and patients;

3. Tumor cell metastasis requires secondary surgery or further radiotherapy and chemotherapy;

4. The high costs of acquisition, operation, and maintenance hinder the widespread adoption of robot-assisted surgery.

To address the aforementioned challenges, Renguan Medical is leading the $50 billion laparoscopic surgery market and pioneering the Laparoscopic Surgery 4.0 era by developing an intelligent, high-precision, and easily controllable smart diagnostic and therapeutic system for laparoscopic procedures. Starting with the pneumoperitoneum support system—an indispensable component of laparoscopic surgery—Renguan Medical has sequentially built its solutions through the integration of intelligent modules.Intelligent Circulating Pneumoperitoneum System, Intelligent Gas-Powered Laparoscopic Robot, and Intelligent Bedside Collaborative Robot for Pneumoperitoneum。Just as humans require respiratory and circulatory systems, intelligent circulating pneumoperitoneum serves as the operational foundation for every laparoscopic surgery., which serves as the prerequisite and guarantee for surgical safety. While major robotics companies started with robotic arms, Renguan Medical began with gas circulation and at the source of laparoscopic surgery. By leveraging an intelligent circulating pneumoperitoneum control system and consumables as its foundation, Renguan has built a comprehensive intelligent hardware platform for laparoscopy. This constitutes the fundamental distinction between Renguan and other laparoscopic surgical equipment manufacturers.

Renguan Medical’s intelligent endoscopic surgical diagnosis and treatment system adheres to the concept of a “bedside collaborative assistive robot” centered on the surgeon. In contrast, large-scale robotic systems represented by the da Vinci Surgical System precisely replicate all of the surgeon’s movements, removing the surgeon from the operating table and placing the robot at the core, with remote teleoperation as the foundational design principle. Renguan Medical believes that regardless of advancements in surgical technology, the lead surgeon remains the central figure throughout the entire surgical procedure. Only by maintaining the surgeon’s “humanized” presence at the bedside can the “personalized” differences among patients be effectively addressed. This is because the essence of life, human subconsciousness, and the instinct for survival cannot be perceived by robots or algorithms.

Meanwhile, given China’s large population base, rapid aging process, substantial patient volume, and highly uneven distribution of physician resources, what the Chinese market truly needs are assisted surgical systems that can reduce the number of physicians required in surgical teams and significantly shorten the training period and learning curve for medical personnel.From the perspective of health economics, what is needed in vast regions of ChinaYesA More Cost-Effective and Price-Competitive Solution. The bedside robotic system by Rengen features a lightweight structure and modular functionality, is fully compatible with existing endoscopic equipment and instruments, and does not alter current surgical workflows and habits. It combines the cost advantages of endoscopic surgery with the technological benefits of robotic systems, aiming to build an endoscopic surgery database for Chinese patients.Better suited to the Chinese market, more aligned with China’s national conditions, and more committed to upholding the value of physicians。

RenGuan Medical (a Suzhou Science and Technology Leading Enterprise) was established in January 2018 in the Suzhou Industrial Park. Rooted in market demand, grounded in scientific research, excelling in innovation, and integrating medicine, engineering, and research, the company has built a 5,000-square-meter manufacturing facility.Equipped with Class 100,000 and Class 10,000 Cleanrooms, two mature production lines ensure stable mass production and supply capabilities.The company has currently obtained3 Product Registration Certificates, 8 Authorized Invention Patents, with PCT applications filed concurrently. Founder Zhu Jian is a leading talent in Suzhou Industrial Park, bringing 20 years of experience in general surgery market sales and innovative R&D (including participation in the National Key Special Project during the 13th Five-Year Plan period). He possesses inherent strengths in both market development and scientific research, leading a team of high-caliber experts from China and abroad to achieve cumulative sales exceeding RMB 3 billion. The founding team includes a chief surgeon from a Grade A tertiary hospital with over 30 years of clinical experience (full-time) and a gynecologist with over 10 years of clinical experience (full-time), who are responsible for clinical liaison and medical-engineering integration; as well as a technical lead with over 10 years of R&D experience in intelligent laparoscopic surgical equipment and robotics, overseeing technological breakthroughs and product implementation. Rencrown Medical TeamIdentified clinical pain points such as the high incidence of pneumoperitoneum-related complications and the hazards of surgical smoke, along with the market prospects for no-touch isolation techniques., the technical team successfully launched GasBalance to the market after five years of algorithm development and product iteration.^®(Gaishibao) Intelligent Circulating Pneumoperitoneum System: Creating a Clear and Stable Intraoperative Environment for Medical Staff, as Well as a Healthy Extraoperative Environment.

Gaisibao Intelligent Circulating Pneumoperitoneum SystemPrecision of Intra-abdominal Pressure and Flow ControlAchieved a world-leading level and established strong technical barriers:

1. Low-flow, low-intra-abdominal-pressure constant-pressure settings can maintain pneumoperitoneum stability at lower pressures, effectively reducing high-flow CO₂₂, mitigates the impact and damage of high intra-abdominal pressure on visceral organs, thereby reducing complications such as gas embolism, hypercapnia, and pain;

2. The fully enclosed circulating smoke evacuation function eliminates the harm caused by surgical smoke to medical staff and patients, reduces the risk of tumor cell metastasis, and creates a healthy, tumor-free surgical environment and outcome;

3. A stable and clear surgical field enhances procedural fluency, reducing operative time by 30%;

4. Meanwhile, the system can completely eliminate the large amount of toxic biochemical substances and infectious viruses contained in surgical smoke, effectively enhancing the protection of medical staff in the context of the COVID-19 pandemic.

Clinical experts have highly acclaimed the system, unanimously agreeing that “Renguan Medical’s Intelligent Circulating Pneumoperitoneum System has pioneered a new concept in pneumoperitoneum. Its low-pressure constant inflation and circulating smoke evacuation effectively safeguard the safety of both surgeons and patients. With no noticeable odors, the surgical field has never been more stable and clear, enabling smoother operative maneuvers and significantly reduced surgery times. Additionally, we feel much less fatigued post-operatively compared to before.”

Renguan Intelligent Circulating Pneumoperitoneum System

Following the successful launch ofIntelligent Circulating PneumoperitoneumBuilding on this system, Rencare Medical is developing an intelligent gasless laparoscopic robot., the prototype is undergoing internal validation.

Key Features of the System:

1. The intelligent circulating pneumoperitoneum module provides a clear and stable surgical field and operating space, functioning like a computer’s operating system to empower other modules to maximize their advantages;

2. Active camera tracking provides the lead surgeon with a real-time view of the target surgical field, moving in sync with their intentions;

3. Enhance surgical workflow efficiency, reduce operative time by 50%, significantly alleviate physical and mental fatigue among medical staff, and lower the risk of inadvertent organ injury by 50%;

4. Eliminates the need for a manual camera holder, reducing operating room staffing requirements and lowering hospital labor costs.

The enhanced control and ease of use provided by the entire system to the lead surgeon have increased the adoption rate of laparoscopic surgery to 1.5 times its current level.

To further enhance the safety of laparoscopic surgery and reduce operational difficulty, Renguan continuesR&DIntelligent Pneumoperitoneum Bedside Collaborative Robot, proof of concept has been completed, and the prototype is currently under development.

Key Features of the System:

1. Equipped with semi-automatic tissue retraction and fixation capabilities, expanding the surgeon’s field of view to three times the current size; the robotic arm design meets the requirements for rapid installation, calibration, and disassembly;

2. Features innovative capabilities such as preoperative planning, intraoperative navigation, postoperative assessment, and intelligent operation;

3. Addressing pain points such as surgeon fatigue leading to procedural errors, limited field of view, risk of accidental organ injury, incomplete surgical planning, and lack of guided positioning;

4. Reduce surgical time by 70%, further alleviating hospital labor costs.

The bedside robotic system developed by Renguan Medical features a simplified structural design, modular functional configuration, and robust compatibility. It significantly reduces the cost of robot-assisted surgery and is suitable for all laparoscopic surgical scenarios, thereby enabling the goals of universal coverage at the primary care level, comprehensive coverage of surgical procedures, and holistic treatment accessibility in robot-assisted surgery.

The endoscopic surgery sector is vast, with over 10,000 target hospitals, more than 50,000 target operating rooms, and a target annual surgical volume of 20 million procedures. The Chinese market size stands at RMB 50 billion, growing at a rate of 20%, while the global market reaches as high as RMB 250 billion. With the iterative launch of Renguang Medical’s products, the company is poised to gradually capture market shares worth RMB 8 billion, RMB 30 billion, and RMB 50 billion.

RenGuan Medical, as a leader in intelligent diagnostic and therapeutic systems for endoscopic surgery,Advocating a physician-centric approach“Bedside Collaborative Assistance Robot” ConceptBy strategically deploying three major product lines, we are ushering in the era of Laparoscopic Surgery 4.0. Starting this year, Rencan Medical will secure at least three product registration certificates annually, with sales experiencing exponential growth. We aim to achieve cumulative sales exceeding RMB 1 billion within five years, realizing our ambitious vision of becoming a leading enterprise in laparoscopic surgery with a market capitalization of RMB 50 billion.